Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.50
Bid: 118.00
Ask: 123.00
Change: 8.00 (7.11%)
Spread: 5.00 (4.237%)
Open: 117.50
High: 120.50
Low: 117.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Oct 2011 15:56

ECO ANIMAL HEALTH GROUP PLC ("ECO Animal" or "the Company")

Issue of Shares and Joint Share Ownership Awards

Issue of new Ordinary Shares

Eco Animal Health Group plc announces that the Company has, on 21 October 2011, issued and allotted a total of 784,000 new ordinary shares of 5p each in the Company ("Ordinary Shares"), representing 1.42 per cent of the enlarged issued share capital of the Company. Of this number, 764,000 were issued at a subscription price of 214p per ordinary share, this being the closing price of a share in the Company on 20 October 2011, pursuant to The ECO Animal Health Group Employees' Joint Share Ownership Plan ("the Plan"), and a further 20,000 were issued at a subscription price of £1.085 as a result of the exercise of options by an employee below board level.

Of the total number of shares issued, 625,000 shares have been issued into the respective joint beneficial ownership of (i) each of the participating executive Directors named below and (ii) the trustee of The ECO Animal Health Group Employees' Share Trust ("the Trust") upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director concerned, the Company and Appleby Trust (Jersey) Limited as trustee of the Trust ("the Trustee"). The subscription price has been paid by the Trust out of funds advanced to it by the Company.

Name of Director Jointly Owned Shares Awarded
Marc Loomes

Brett Clemo

Kevin Stockdale

Julia Trouse

225,000

150,000

125,000

125,000

The balance remaining of 159,000 shares have been issued to four other employees and the Trust upon and subject to JOA's on terms similar to those entered into by the executive directors on this occasion.

Application for admission to AIM of the 784,000 new Ordinary Shares has been made and it is expected that admission will happen on 27 October 2011.

The Directors of the Company will, following admission, hold beneficial interests as follows:

Name of Director No. of whole Shares in which the Director is interested No. of Shares in which the Director has an interest under the terms of a JOA or approved option scheme
Marc Loomes

Brett Clemo

Kevin Stockdale

Julia Trouse

-

4,519

8,051

3,291

1,158,750

460,000

390,000

546,100

Disclosure and Transparency Rules

In accordance with the FSA's Disclosure and Transparency Rules, the Company's issued share capital following the admission of the Ordinary Shares will comprise 55,030,451 ordinary shares of 5p with voting rights.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Enquiries:

ECO Animal Health Group plc Kevin Stockdale, Finance tel: 0208 336 6186
Director

Peter Lawrence, Chairman

tel: 0208 336 6190

Cenkos Securites Ltd (Nominated Adviser) Elizabeth Bowman tel: 0207 397 8928

**********************************************

Copyright Business Wire 2011

Date   Source Headline
8th May 20247:00 amRNSRisk Profile Demonstrated for ECOVAXXIN MS
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.